Accendra Health Inc
ACH- Exchange
- NYSE
- Industry
- Wholesale-Medical, Dental & Hospital Equipment & Supplies
- SEC CIK
- 0000075252
No open-market purchases or sales by Accendra Health Inc insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $213.2M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 139
- 13F valueReported value at the end of Q2 2026
- $213.2M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ACH, Q2 2026
No superinvestor reported holding ACH at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Accendra Health Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 (view filing)8:23 PM ET | Aug 12 | 2 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +720.0K | $5.15 | +$3.71M | +6.2%12.3M after | |
| Aug 14, 2025 (view filing)8:23 PM ET | Aug 13-14 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +817.9K | $5.37 | +$4.39M | +6.7%13.1M after | 2 lots |
| Apr 10, 2025 (view filing)9:43 PM ET | Apr 8 | 2 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +105.0K | $7.96 | +$835.8K | +0.9%11.3M after | |
| Apr 10, 2025 (view filing)9:43 PM ET | Apr 9-10 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +305.0K | $7.34 | +$2.24M | +2.7%11.6M after | 2 lots |
| Apr 7, 2025 (view filing)8:21 PM ET | Apr 3 | 4 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +160.0K | $8.53 | +$1.36M | +1.5%10.8M after | |
| Apr 7, 2025 (view filing)8:21 PM ET | Apr 4-7 | 3 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +368.4K | $7.94 | +$2.93M | +3.4%11.2M after | 2 lots |
| Mar 4, 2025 (view filing)9:07 PM ET | Feb 28 | 4 days | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchaseCommon Stock, par value $2 per share ("Common Stock") | +1.74M | $9.39 | +$16.3M | +22.5%9.47M after | |
| Mar 4, 2025 (view filing)9:07 PM ET | Mar 3-4 | 1 day | Coliseum Capital Partners, L.P. and 4 others10% Owner | PPurchase | +1.15M | $9.58 | +$11.1M | +12.2%10.6M after | 2 lots |
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Leon Jonathan AEVP, Chief Financial Officer | SSale | −5.28K | $11.82 | −$62.4K | −3.9%130.8K after | 10b5-1 |
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | Sarkar SnehashishOther: Chief Information Officer | SSale | −2.06K | $12.26 | −$25.2K | −3.5%55.9K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Accendra Health Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Coliseum Capital Management, LLC | 13,100,807 | $44.8M | 3.85% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,504,102 | $18.8M | 0.00% | +268,802+5.1% | Added |
| Bank of America Corp | 3,775,525 | $12.9M | 0.00% | +368,450+10.8% | Added |
| Vanguard Capital Management LLC | 3,087,931 | $10.6M | 0.00% | −194,243−5.9% | Reduced |
| D. E. Shaw & Co., Inc. | 3,081,407 | $10.5M | 0.01% | −230,194−7.0% | Reduced |
| Charles Schwab Investment Management Inc | 2,888,058 | $9.88M | 0.00% | −747,468−20.6% | Reduced |
| Invenomic Capital Management LP | 2,812,474 | $9.62M | 0.57% | −556,501−16.5% | Reduced |
| Marshall Wace, LLP | 2,582,579 | $8.83M | 0.01% | +821,575+46.7% | Added |
| Paradigm Capital Management Inc | 2,536,699 | $8.68M | 0.24% | +750,299+42.0% | Added |
| Vanguard Portfolio Management LLC | 2,030,956 | $6.95M | 0.00% | −620,196−23.4% | Reduced |